Exact Mass: 372.18311680000005
Exact Mass Matches: 372.18311680000005
Found 77 metabolites which its exact mass value is equals to given mass value 372.18311680000005,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Biocytin
C16H28N4O4S (372.18311680000005)
Biocytin is a naturally occurring low molecular weight analog of biotin, and a primary source of this essential metabolite for mammals. Biotinidase acts as a hydrolase by cleaving biocytin and biotinyl-peptides, thereby liberating biotin for reutilization. Mammals cannot synthesize biotin and, therefore, derive the vitamin from dietary sources or from the endogenous turnover of the carboxylases. Free biotin can readily enter the biotin pool, whereas holocarboxylases or other biotin-containing proteins must first be degraded proteolytically to biocytin (biotinyl-e-lysine) or biotinyl-peptides. Biocytin is also an especially versatile marker for neuroanatomical investigations, shown that may have multiple applications, especially for labeling neurons. (PMID: 8930409, 1384763, 2479450) [HMDB] Biocytin is a naturally occurring low molecular weight analog of biotin, and a primary source of this essential metabolite for mammals. Biotinidase acts as a hydrolase by cleaving biocytin and biotinyl-peptides, thereby liberating biotin for reutilization. Mammals cannot synthesize biotin and, therefore, derive the vitamin from dietary sources or from the endogenous turnover of the carboxylases. Free biotin can readily enter the biotin pool, whereas holocarboxylases or other biotin-containing proteins must first be degraded proteolytically to biocytin (biotinyl-e-lysine) or biotinyl-peptides. Biocytin is also an especially versatile marker for neuroanatomical investigations, shown that may have multiple applications, especially for labeling neurons. (PMID:8930409, 1384763, 2479450).
Acebutolol HCl
C18H29ClN2O4 (372.18157440000004)
C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D013566 - Sympathomimetics D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents D002317 - Cardiovascular Agents > D000889 - Anti-Arrhythmia Agents Acebutolol hydrochloride is an orally active β1 adrenergic receptor (β1AR) antagonist. Acebutolol hydrochloride is used in the treatment of hypertension, angina pectoris and cardiac arrhythmias[1][2][3].
Pyroglutamyl-phenylalanyl-prolinamide
2,4-Di-Me ether,1-O-beta-D-glucopyranoside-6-(1-Methylpropyl)-1,2,4-benzenetriol
2,6-dimethyl-3-hydroxymethyl-5-oxo-1,6-heptadiene-9-O-(6-acetyl-beta-D-glucopyranoside)
4-hydroxy-2-(3-hydroxy-3-methylbutyl)-5-methylphenyl beta-D-glucopyranoside|4-Hydroxy-2-[3-hydroxy-3-methylbutyl]-5-methylphenyl ??-D-glucopyranoside
(3S)-3-hydroxysedanolide beta-D-glucopyranoside|celephthalide C
5,5,6-Trimethyl-6-(1,2,3-triacetoxy-butyl)-tetrahydro-pyran-2-on|5,5,6-trimethyl-6-(1,2,3-triacetoxy-butyl)-tetrahydro-pyran-2-one
5-(6-hydroxyhexyl)benzene-1,3-diol 1-O-beta-D-glucopyranoside|5-(6-hydroxyhexyl)resorcinol 1-O-beta-D-glucopyranoside|grevilloside H
1-Aldehyde,8-O-(2-acetyl-beta-D-glucopyranoside)-(E)-2-Methyl-6-methylene-2-octene-1,8-diol|7-Formyl-3-methylene-6E-octenol-O-beta-D-(2-O-acetylglucopyranoside)|7-Formyl-3-methylene-6E-octenol-O-beta-D-<2-O-acetylglucopyranoside>
Biocytin
C16H28N4O4S (372.18311680000005)
A monocarboxylic acid amide that results from the formal condensation of the carboxylic acid group of biotin with the N(6)-amino group of L-lysine.
1-amino-5-(trityloxymethyl)pyrrolidin-2-one
C24H24N2O2 (372.18376839999996)
[1-{[(2-Methyl-2-propanyl)oxy]carbonyl}-5-(1-piperidinylcarbonyl) -1H-indol-2-yl]boronic acid
benzoic acid,2,2-dimethylpropane-1,3-diol,hexanedioic acid
N,N-(Methylene-p-phenylene)-bis-[N-(2-hydroxyethyl)]urea
N-[(1R)-1-Hydroperoxy-3-methylbutyl]-Nα-(2-pyrazinylcarbonyl)-L-phenylalaninamide
N-[(1S)-1-Hydroperoxy-3-methylbutyl]-Nα-(2-pyrazinylcarbonyl)-L-phenylalaninamide
(2R,3R)-3-(tert-butyl)-4-(2,6-dimethoxyphenyl)-2-isopropyl-2,3-dihydrobenzo[d][1,3]oxaphosphole
C22H29O3P (372.18542140000005)
(2S,3S)-3-(tert-butyl)-4-(2,6-dimethoxyphenyl)-2-isopropyl-2,3-dihydrobenzo[d][1,3]oxaphosphole
C22H29O3P (372.18542140000005)
N-Cbz-L-lysine tert-butyl ester hydrochloride
C18H29ClN2O4 (372.18157440000004)
(R)-2-Amino-3-((3-octylphenyl)amino)-3-oxopropyl dihydrogen phosphate
C17H29N2O5P (372.18139940000003)
D007155 - Immunologic Factors > D007166 - Immunosuppressive Agents > D000081243 - Sphingosine 1 Phosphate Receptor Modulators
5-(2-Aminoethyl)-3-{5-[amino(iminio)methyl]-1H-benzimidazol-2-YL}-1,1-biphenyl-2-olate
Biocytin zwitterion
C16H28N4O4S (372.18311680000005)
An L-alpha-amino acid zwitterion obtained by transfer of a proton from the carboxy to the amino group of biocytin; major species at pH 7.3.
7-O-acetylsalutaridinol(1+)
C21H26NO5+ (372.18108860000007)
The conjugate acid of 7-O-acetylsalutaridinol arising from protonation of the tertiary amino function.
methyl-[(7S)-1,2,3,10-tetramethoxy-9-oxo-6,7-dihydro-5H-benzo[a]heptalen-7-yl]azanium
C21H26NO5+ (372.18108860000007)
4-[[(4-tert-butylphenyl)-oxomethyl]hydrazo]-N-(5-methyl-3-isoxazolyl)-4-oxobutanamide
N-[2-(3-ethoxypropylamino)-1-(4-methoxyphenyl)-2-oxoethyl]-2-pyrazinecarboxamide
N-(2-methoxyphenyl)-4,6-bis(4-morpholinyl)-1,3,5-triazin-2-amine
C18H24N6O3 (372.19097939999995)
17beta-(Acetylthio)estra-1,3,5(10)-trien-3-ol acetate
(1S,5R)-7-[4-[(Z)-prop-1-enyl]phenyl]-6-[[2-(trifluoromethyl)phenyl]methyl]-3,6-diazabicyclo[3.1.1]heptane
(4Z)-2-Ethyl-4-[(4-ethylphenyl)methylidene]-1,3-dihydrobenzo[b][1,6]naphthyridine-10-carboxylic acid
C24H24N2O2 (372.18376839999996)
(2S)-2-amino-6-[[4-amino-1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-1-ium-2-yl]amino]hexanoic acid
2,3-Dihydroxypropyl (2-hydroxy-3-nonoxypropyl) hydrogen phosphate
C15H33O8P (372.19129480000004)
(3S)-3-(Tert-butyldimethylsilyloxy)-5-tosylpentanol
[(2r,3s,4s,5r,6r)-3,4,5-trihydroxy-6-{[(2r)-5-methyl-4-oxo-2-(prop-1-en-2-yl)hex-5-en-1-yl]oxy}oxan-2-yl]methyl acetate
3-[3-hydroxy-1-methoxy-1-(2-methylpropyl)-6-oxo-4h-pyrazino[2,1-b]quinazolin-4-yl]propanimidic acid
4-(2,6,6- trimethyl-1- cyclohexen-1- yl)-3- buten-2- on
{"Ingredient_id": "HBIN009861","Ingredient_name": "4-(2,6,6- trimethyl-1- cyclohexen-1- yl)-3- buten-2- on","Alias": "NA","Ingredient_formula": "C19H24N4O4","Ingredient_Smile": "CC1=CCCC(C1C=CC(=NNC2=C(C=C(C=C2)[N+](=O)[O-])[N+](=O)[O-])C)(C)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "42888","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
4-hydroxy-2-[3-hydroxy-3-methylbutyl]-5-methylphenylβ-d-glucopyranoside
{"Ingredient_id": "HBIN010435","Ingredient_name": "4-hydroxy-2-[3-hydroxy-3-methylbutyl]-5-methylphenyl\u03b2-d-glucopyranoside","Alias": "NA","Ingredient_formula": "C18H28O8","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "10199","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
3-[(1r,4s)-1-tert-butyl-3-hydroxy-1-methoxy-6-oxo-4h-pyrazino[2,1-b]quinazolin-4-yl]propanimidic acid
(1r,6s,9s,10s,14s,16r,17r,18s,19s)-9,17,18,19-tetrahydroxy-14-methyl-3,15,20-trioxatricyclo[14.3.1.0⁶,¹⁰]icos-12-en-4-one
(2s,3r,4s,5s,6r)-2-[4-hydroxy-2-(3-hydroxy-3-methylbutyl)-5-methylphenoxy]-6-(hydroxymethyl)oxane-3,4,5-triol
(3r,3as)-3-[(3s)-3-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}butyl]-3a,4,5,6-tetrahydro-3h-2-benzofuran-1-one
(2s,3r,4s,5s,6r)-2-[3-hydroxy-5-(6-hydroxyhexyl)phenoxy]-6-(hydroxymethyl)oxane-3,4,5-triol
(3,4,5-trihydroxy-6-{[5-methyl-4-oxo-2-(prop-1-en-2-yl)hex-5-en-1-yl]oxy}oxan-2-yl)methyl acetate
2-[4-hydroxy-2-(3-hydroxy-3-methylbutyl)-5-methylphenoxy]-6-(hydroxymethyl)oxane-3,4,5-triol
3-[(1r,4s)-3-hydroxy-1-methoxy-1-(2-methylpropyl)-6-oxo-4h-pyrazino[2,1-b]quinazolin-4-yl]propanimidic acid
2-amino-4-{[1-(3,5-dimethoxy-2-methyl-6-oxocyclohex-1-en-1-yl)-1-hydroxypropan-2-yl]-c-hydroxycarbonimidoyl}butanoic acid
(3r,5r)-8-decyl-3,4-dihydroxy-2,6-dioxo-1,7-dioxaspiro[4.4]nonane-4-carboxylic acid
(2s)-2-amino-4-{[(1r,2s)-1-[(3s,5s)-3,5-dimethoxy-2-methyl-6-oxocyclohex-1-en-1-yl]-1-hydroxypropan-2-yl]-c-hydroxycarbonimidoyl}butanoic acid
(6s,12bs)-4,12-dihydroxy-3,10,11-trimethoxy-6-methyl-7,8,12b,13-tetrahydro-5h-6-azatetraphen-6-ium
[C21H26NO5]+ (372.18108860000007)
9,17,18,19-tetrahydroxy-14-methyl-3,15,20-trioxatricyclo[14.3.1.0⁶,¹⁰]icos-12-en-4-one
{[8,11-dihydroxy-10-(sec-butyl)-2-oxa-6,9,12-triazatricyclo[13.2.2.0³,⁷]nonadeca-1(17),8,11,15,18-pentaen-6-yl]methylidyne}oxidanium
[C20H26N3O4]+ (372.19232160000007)